[
Anagnostis P, Tarlatzis BC, Kauffman RP. Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. Metabolism 86, 33–43, 2018.
]Search in Google Scholar
[
Anderson SA, Barry JA, Hardiman PJ. Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: a systematic review and meta-analysis. Int J Cardiol 176, 486–487, 2014.
]Search in Google Scholar
[
Baldani DP, Skrgatic L, Goldstajn MS, Zlopasa G, Oguic SK, Canic T, Piljek AN. Clinical and biochemical characteristics of polycystic ovary syndrome in Croatian population. Coll Antropol 36, 1413–1418, 2012.
]Search in Google Scholar
[
Barber TM, McCarthy MI, Wass JA, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) 65, 137–145, 2006.
]Search in Google Scholar
[
Behboudi-Gandevani S, Amiri M, Bidhendi Yarandi R, Noroozzadeh M, Farahmand M, Rostami Dovom M, Ramezani Tehrani F. The risk of metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis. Clin Endocrinol (Oxf) 88, 169–184, 2018.
]Search in Google Scholar
[
Bulsara J, Patel P, Soni A, Acharya S. A review: Brief insight into polycystic ovarian syndrome. Endocr Metab Sci 3, 100085, 2021.
]Search in Google Scholar
[
Cassar S, Misso ML, Hopkins WG, Shaw CS, Teede HJ, Stepto NK. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies. Hum Reprod 31, 2619–2631, 2016.
]Search in Google Scholar
[
Cheung LP, Ma RC, Lam PM, Lok IH, Haines CJ, So WY, Tong PC, Cockram CS, Chow CC, Goggins WB. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome. Hum Reprod 23, 1431–1438, 2008.
]Search in Google Scholar
[
Cooney LG, Dokras A. Beyond fertility: polycystic ovary syndrome and long-term health. Fertil Steril 110, 794–809, 2018.
]Search in Google Scholar
[
Costa EC, Sa JC, Soares EM, Lemos TM, Maranhao TM, Azevedo GD. Anthropometric indices of central obesity how discriminators of metabolic syndrome in Brazilian women with polycystic ovary syndrome. Gynecol Endocrinol 28, 12–15, 2012.
]Search in Google Scholar
[
Crosignani PG, Colombo M, Vegetti W, Somigliana E, Gessati A, Ragni G. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod 18, 1928–1932, 2003.
]Search in Google Scholar
[
El Hayek S, Bitar L, Hamdar LH, Mirza FG, Daoud G. Polycystic ovarian syndrome: an updated overview. Front Physiol 7, 124, 2016.
]Search in Google Scholar
[
Escobar-Morreale HF, Roldan-Martin MB. Type 1 diabetes and polycystic ovary syndrome: systematic review and meta-analysis. Diabetes Care 39, 639–648, 2016.
]Search in Google Scholar
[
Essah PA, Nestler JE, Carmina E. Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome. J Endocrinol Invest 31, 35–41, 2008.
]Search in Google Scholar
[
Gateva A, Kamenov Z. Anthropometric indices of visceral obesity and cardiovascular risk factors in patients with polycystic ovarian syndrome. In Endocrine Abstracts 29, P900, 2012.
]Search in Google Scholar
[
Glueck CJ, Dharashivkar S, Wang P, Zhu B, Gartside PS, Tracy T, Sieve L. Obesity and extreme obesity, manifest by ages 20–24 years, continuing through 32–41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy. Eur J Obstet Gynecol Reprod Biol 122, 206–212, 2005.
]Search in Google Scholar
[
Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics. Metabolism 92, 108–120, 2019.
]Search in Google Scholar
[
Gunning MN, Fauser BCJM. Are women with polycystic ovary syndrome at increased cardiovascular disease risk later in life? Climacteric 20, 222–227, 2017.
]Search in Google Scholar
[
Harada M. Pathophysiology of polycystic ovary syndrome revisited: Current understanding and perspectives regarding future research. Reprod Med Biol 21, e12487, 2022.
]Search in Google Scholar
[
Kaluzna M, Czlapka-Matyasik M, Wachowiak-Ochmanska K, Moczko J, Kaczmarek J, Janicki A, Piatek K, Ruchala M, Ziemnicka K. Effect of central obesity and hyperandrogenism on selected inflammatory markers in patients with PCOS: a WHtR-matched case-control study. J Clin Med 9, 3024, 2020.
]Search in Google Scholar
[
Kaluzna M, Czlapka-Matyasik M, Kompf P, Moczko J, Wachowiak-Ochmanska K, Janicki A, Samarzewska K, Ruchala M, Ziemnicka K. Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome. Ther Adv Endocrinol Metab 13, 20420188211066699, 2022.
]Search in Google Scholar
[
Karabulut A, Yaylali GF, Demirlenk S, Sevket O, Acun A. Evaluation of body fat distribution in PCOS and its association with carotid atherosclerosis and insulin resistance. Gynecol Endocrinol 28, 111–114, 2012.
]Search in Google Scholar
[
Khan MM, Sonkar GK, Alam R, Mehrotra S, Khan MS, Kumar A, Sonkar SK. Validity of Indian Diabetes Risk Score and its association with body mass index and glycosylated hemoglobin for screening of diabetes in and around areas of Lucknow. J Family Med Prim Care 6, 366–373, 2017.
]Search in Google Scholar
[
Kheirollahi A, Teimouri M, Karimi M, Vatannejad A, Moradi N, Borumandnia N, Sadeghi A. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women. Lipids Health Dis 19, 235, 2020.
]Search in Google Scholar
[
Kumar AN, Naidu JN, Satyanarayana U, Ramalingam K, Anitha M. Metabolic and endocrine characteristics of Indian women with polycystic ovary syndrome. Int J Fertil Steril 10, 22–28, 2016.
]Search in Google Scholar
[
Legro RS. Obesity and PCOS: implications for diagnosis and treatment. Semin Reprod Med 30, 496–506, 2012.
]Search in Google Scholar
[
Lunde O, Tanbo T. Polycystic ovary syndrome: a follow-up study on diabetes mellitus, cardiovascular disease and malignancy 15-25 years after ovarian wedge resection. Gynecol Endocrinol 23, 704–709, 2007.
]Search in Google Scholar
[
Mani H, Levy MJ, Davies MJ, Morris DH, Gray LJ, Bankart J, Blackledge H, Khunti K, Howlett TA. Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study. Clin Endocrinol (Oxf) 78, 926–934, 2013.
]Search in Google Scholar
[
McCartney ChR, Marshall JC. Polycystic ovary syndrome. N Engl J Med 375, 1398–1399, 2016.
]Search in Google Scholar
[
Mimouni NE, Paiva I, Barbotin AL, Timzoura FE, Plassard D, Le Gras S, Ternier G, Pigny P, Catteau-Jonard S, Simon V, Prevot V, Boutillier AL, Giacobini P. Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process. Cell Metabol 33, 513–530, 2021.
]Search in Google Scholar
[
Naidu JN, Swapna GN, Kumar AN, Krishnamma M, Anitha M. Importance of elevated insulin resistance, dyslipidemia and status of antioxidant vitamins in polycystic ovary disease. Free Rad Antiox 3, 17–19, 2013.
]Search in Google Scholar
[
Prajapati P. A lipid profile study in polycystic ovary syndrome women. Int J Reprod Contracept Obstet Gynecol 12, 234–239, 2023.
]Search in Google Scholar
[
Puttabyatappa M, Padmanabhan V. Ovarian and extra-ovarian mediators in the development of polycystic ovary syndrome. J Mol Endocrinol 61, R161–R184, 2018.
]Search in Google Scholar
[
Rojas J, Chavez M, Olivar L, Rojas M, Morillo J, Mejias J, Calvo M, Bermudez V. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Inter J Reprod Med 2014, 719050, 2014.
]Search in Google Scholar
[
Sahmay S, Aydogan Mathyk B, Sofiyeva N, Atakul N, Azemi A, Erel T. Serum AMH levels and insulin resistance in women with PCOS. Eur J Obstet Gynecol Reprod Biol 224, 159–164, 2018.
]Search in Google Scholar
[
Status WP. The use and interpretation of anthropometry. WHO technical report series 854, 1995.
]Search in Google Scholar
[
Stener-Victorin E, Deng Q. Epigenetic inheritance of polycystic ovary syndrome—Challenges and opportunities for treatment. Nat Rev Endocrinol 17, 521–533, 2021.
]Search in Google Scholar
[
Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ; International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod 33, 1602–1618, 2018.
]Search in Google Scholar
[
Thathapudi S, Kodati V, Erukkambattu J, Katragadda A, Addepally U, Hasan Q. Anthropometric and biochemical characteristics of polycystic ovarian syndrome in South Indian women using AES-2006 criteria. Int J Endocrinol Metab 12, e12470, 2014.
]Search in Google Scholar
[
Vekic J, Zeljkovic A, Stefanovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V. Obesity and dyslipidemia. Metabolism 92, 71–81, 2019.
]Search in Google Scholar
[
Wekker V, van Dammen L, Koning A, Heida KY, Painter RC, Limpens J, Laven JSE, Roeters van Lennep JE, Rose-boom TJ, Hoek A. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update 26, 942–960, 2020.
]Search in Google Scholar
[
Wild RA, Rizzo M, Clifton S, Carmina E. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril 95, 1073–1079.e1–11, 2011.
]Search in Google Scholar
[
Yuan C, Liu X, Mao Y, Diao F, Cui Y, Liu J. Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study. J Biomed Res 30, 197–202, 2016.
]Search in Google Scholar
[
Zhao L, Zhu Z, Lou H, Zhu G, Huang W, Zhang S, Liu F. Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis. Oncotarget 7, 33715–33721, 2016.
]Search in Google Scholar
[
Zhu T, Cui J, Goodarzi MO. Polycystic ovary syndrome and risk of type 2 diabetes, coronary heart disease, and stroke. Diabetes 70, 627–637, 2021.
]Search in Google Scholar
